The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial

By rosaguerrero • September 30, 2022

Monteiro ACC, Vangala S, Wick KD, Delucchi KL, Siegel ER, Thompson BT, Liu KD, Sapru A, Sinha P, Matthay MA; NHLBI PETAL Network. The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial. Crit Care. 2022 Sep 29;26(1):297. doi: 10.1186/s13054-022-04179-7. PMID: 36175982.

Tags: APACHE-III, ARDS, Neuromuscular blockade, Publications, Pulmonary, Critical Care & Sleep Medicine, ROSE trial, Ventilatory ratio

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival

Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching PA, Bardia A, Chia S, Im SA, Martin M, Xu B, Barrios CH, Untch M, Moroose[...]

Obesity mortality on the rise: A 54-year US perspective

Aamir J, Afridi MK, Sajid M, Khan TM, Qureshi S, Ahmed R, Fonarow GC, Minhas AMK, Waqas SA. Obesity mortality on the rise: A 54-year[...]

Screening for Hepatocellular Carcinoma Recurrence After Liver Transplantation: Prospective Validation of Binary Criteria

Dixon W, Chandna S, Sack JS, Gray M, Brown CN, Poreddy S, Ha K, Schoech MR, Zucker SD. Screening for Hepatocellular Carcinoma Recurrence After Liver[...]